COLL - Financial Reports List - Collegium Pharmaceutical, Inc. - IntrinsicAlpha

Collegium Pharmaceutical, Inc. COLL

Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US

$ 27.38

-2.7 %

$ 862 M

Market Cap

14.72

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	21.51%	-60.75%	-38.22%
Annual Report	FY	10-K	2024-12-31	11.41%	43.68%	1.76%
Quarterly Report	Q3	8-K	2024-09-30	16.53%	-54.76%	-22.60%
Quarterly Report	Q2	8-K	2024-06-30	7.18%	50.73%	33.22%
Quarterly Report	Q1	8-K	2024-03-31	0.11%	259.03%	100.89%
Quarterly Report	Q4	8-K	2023-12-31	15.53%	543.67%	303.46%
Annual Report	FY	10-K	2023-12-31	22.17%	292.60%	259.66%
Quarterly Report	Q3	8-K	2023-09-30	7.63%	4415.10%	119.93%
Quarterly Report	Q2	8-K	2023-06-30	9.71%	350.57%	220.73%
Quarterly Report	Q1	8-K	2023-03-31	72.85%	-33.34%	346.00%

1